UniProt ID | TAF3_HUMAN | |
---|---|---|
UniProt AC | Q5VWG9 | |
Protein Name | Transcription initiation factor TFIID subunit 3 | |
Gene Name | TAF3 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 929 | |
Subcellular Localization | Nucleus . | |
Protein Description | Transcription factor TFIID is one of the general factors required for accurate and regulated initiation by RNA polymerase II. TFIID is a multimeric protein complex that plays a central role in mediating promoter responses to various activators and repressors. Required in complex with TBPL2 for the differentiation of myoblasts into myocytes. The complex replaces TFIID at specific promoters at an early stage in the differentiation process.. | |
Protein Sequence | MCESYSRSLLRVSVAQICQALGWDSVQLSACHLLTDVLQRYLQQLGRGCHRYSELYGRTDPILDDVGEAFQLMGVSLHELEDYIHNIEPVTFPHQIPSFPVSKNNVLQFPQPGSKDAEERKEYIPDYLPPIVSSQEEEEEEQVPTDGGTSAEAMQVPLEEDDELEEEEIINDENFLGKRPLDSPEAEELPAMKRPRLLSTKGDTLDVVLLEAREPLSSINTQKIPPMLSPVHVQDSTDLAPPSPEPPMLAPVAKSQMPTAKPLETKSFTPKTKTKTSSPGQKTKSPKTAQSPAMVGSPIRSPKTVSKEKKSPGRSKSPKSPKSPKVTTHIPQTPVRPETPNRTPSATLSEKISKETIQVKQIQTPPDAGKLNSENQPKKAVVADKTIEASIDAVIARACAEREPDPFEFSSGSESEGDIFTSPKRISGPECTTPKASTSANNFTKSGSTPLPLSGGTSSSDNSWTMDASIDEVVRKAKLGTPSNMPPNFPYISSPSVSPPTPEPLHKVYEEKTKLPSSVEVKKKLKKELKTKMKKKEKQRDREREKDKNKDKSKEKDKVKEKEKDKETGRETKYPWKEFLKEEEADPYKFKIKEFEDVDPKVKLKDGLVRKEKEKHKDKKKDREKGKKDKDKREKEKVKDKGREDKMKAPAPPLVLPPKELALPLFSPATASRVPAMLPSLLPVLPEKLFEEKEKVKEKEKKKDKKEKKKKKEKEKEKKEKEREKEKREREKREKEKEKHKHEKIKVEPVALAPSPVIPRLTLRVGAGQDKIVISKVVPAPEAKPAPSQNRPKTPPPAPAPAPGPMLVSPAPVPLPLLAQAAAGPALLPSPGPAASGASAKAPVRSVVTETVSTYVIRDEWGNQIWICPGCNKPDDGSPMIGCDDCDDWYHWPCVGIMTAPPEEMQWFCPKCANKKKDKKHKKRKHRAH | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
|
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
52 | Phosphorylation | LGRGCHRYSELYGRT HCCHHHHHHHHHCCC | 5.26 | - | |
56 | Phosphorylation | CHRYSELYGRTDPIL HHHHHHHHCCCCCCH | 10.66 | - | |
114 | Phosphorylation | LQFPQPGSKDAEERK ECCCCCCCCCHHHHH | 33.76 | 25159151 | |
183 | Phosphorylation | LGKRPLDSPEAEELP CCCCCCCCCCHHHCC | 32.11 | 29255136 | |
199 | Phosphorylation | MKRPRLLSTKGDTLD CCCCCCCCCCCCCEE | 32.44 | 22617229 | |
200 | Phosphorylation | KRPRLLSTKGDTLDV CCCCCCCCCCCCEEE | 38.73 | 27273156 | |
204 | Phosphorylation | LLSTKGDTLDVVLLE CCCCCCCCEEEEEEE | 33.26 | 22617229 | |
221 | Phosphorylation | EPLSSINTQKIPPML CCHHHCCCCCCCCCC | 29.57 | 26074081 | |
229 | Phosphorylation | QKIPPMLSPVHVQDS CCCCCCCCCCEECCC | 20.72 | 25159151 | |
236 | Phosphorylation | SPVHVQDSTDLAPPS CCCEECCCCCCCCCC | 13.51 | 30278072 | |
237 | Phosphorylation | PVHVQDSTDLAPPSP CCEECCCCCCCCCCC | 43.23 | 30278072 | |
243 | Phosphorylation | STDLAPPSPEPPMLA CCCCCCCCCCCCCCC | 40.62 | 25159151 | |
255 | Phosphorylation | MLAPVAKSQMPTAKP CCCCHHHCCCCCCCC | 23.21 | 26074081 | |
256 | Phosphorylation | LAPVAKSQMPTAKPL CCCHHHCCCCCCCCC | 40.96 | 20736484 | |
257 | Phosphorylation | APVAKSQMPTAKPLE CCHHHCCCCCCCCCC | 4.04 | 20736484 | |
259 | Phosphorylation | VAKSQMPTAKPLETK HHHCCCCCCCCCCCC | 41.81 | 26074081 | |
261 | Acetylation | KSQMPTAKPLETKSF HCCCCCCCCCCCCCC | 53.25 | 25953088 | |
265 | Phosphorylation | PTAKPLETKSFTPKT CCCCCCCCCCCCCCC | 39.40 | 29083192 | |
266 | Acetylation | TAKPLETKSFTPKTK CCCCCCCCCCCCCCC | 33.91 | 19608861 | |
267 | Phosphorylation | AKPLETKSFTPKTKT CCCCCCCCCCCCCCC | 41.60 | 22817900 | |
269 | Phosphorylation | PLETKSFTPKTKTKT CCCCCCCCCCCCCCC | 30.85 | 24719451 | |
272 | Phosphorylation | TKSFTPKTKTKTSSP CCCCCCCCCCCCCCC | 45.19 | 29083192 | |
276 | Phosphorylation | TPKTKTKTSSPGQKT CCCCCCCCCCCCCCC | 39.40 | 28176443 | |
277 | Phosphorylation | PKTKTKTSSPGQKTK CCCCCCCCCCCCCCC | 35.77 | 28176443 | |
278 | Phosphorylation | KTKTKTSSPGQKTKS CCCCCCCCCCCCCCC | 37.98 | 28176443 | |
288 | Phosphorylation | QKTKSPKTAQSPAMV CCCCCCCCCCCCCCC | 33.06 | 23927012 | |
291 | Phosphorylation | KSPKTAQSPAMVGSP CCCCCCCCCCCCCCC | 16.50 | 23927012 | |
294 | Sulfoxidation | KTAQSPAMVGSPIRS CCCCCCCCCCCCCCC | 3.89 | 21406390 | |
297 | Phosphorylation | QSPAMVGSPIRSPKT CCCCCCCCCCCCCCC | 13.02 | 25159151 | |
301 | Phosphorylation | MVGSPIRSPKTVSKE CCCCCCCCCCCCCCC | 31.31 | 23927012 | |
304 | Phosphorylation | SPIRSPKTVSKEKKS CCCCCCCCCCCCCCC | 33.14 | 26074081 | |
315 | Phosphorylation | EKKSPGRSKSPKSPK CCCCCCCCCCCCCCC | 43.32 | 23911959 | |
317 | Phosphorylation | KSPGRSKSPKSPKSP CCCCCCCCCCCCCCC | 38.51 | 24275569 | |
320 | Phosphorylation | GRSKSPKSPKSPKVT CCCCCCCCCCCCCCC | 40.73 | 23911959 | |
323 | Phosphorylation | KSPKSPKSPKVTTHI CCCCCCCCCCCCCCC | 33.08 | 23911959 | |
327 | Phosphorylation | SPKSPKVTTHIPQTP CCCCCCCCCCCCCCC | 20.84 | 29978859 | |
328 | Phosphorylation | PKSPKVTTHIPQTPV CCCCCCCCCCCCCCC | 22.31 | 29978859 | |
333 | Phosphorylation | VTTHIPQTPVRPETP CCCCCCCCCCCCCCC | 20.56 | 30266825 | |
339 | Phosphorylation | QTPVRPETPNRTPSA CCCCCCCCCCCCCCC | 28.66 | 30266825 | |
343 | Phosphorylation | RPETPNRTPSATLSE CCCCCCCCCCCCCCH | 28.38 | 25159151 | |
345 | Phosphorylation | ETPNRTPSATLSEKI CCCCCCCCCCCCHHH | 33.02 | 29978859 | |
347 | Phosphorylation | PNRTPSATLSEKISK CCCCCCCCCCHHHCC | 34.84 | 29978859 | |
349 | Phosphorylation | RTPSATLSEKISKET CCCCCCCCHHHCCCC | 32.27 | 29978859 | |
360 | Acetylation | SKETIQVKQIQTPPD CCCCEEEEECCCCCC | 25.88 | 26051181 | |
364 | Phosphorylation | IQVKQIQTPPDAGKL EEEEECCCCCCCCCC | 38.12 | 30266825 | |
370 | Ubiquitination | QTPPDAGKLNSENQP CCCCCCCCCCCCCCC | 46.33 | 29967540 | |
370 | Acetylation | QTPPDAGKLNSENQP CCCCCCCCCCCCCCC | 46.33 | 25953088 | |
373 | Phosphorylation | PDAGKLNSENQPKKA CCCCCCCCCCCCCCE | 48.65 | 30266825 | |
410 | Phosphorylation | EPDPFEFSSGSESEG CCCCCCCCCCCCCCC | 26.96 | 21082442 | |
411 | Phosphorylation | PDPFEFSSGSESEGD CCCCCCCCCCCCCCC | 52.22 | 20873877 | |
413 | Phosphorylation | PFEFSSGSESEGDIF CCCCCCCCCCCCCCC | 39.64 | 20873877 | |
415 | Phosphorylation | EFSSGSESEGDIFTS CCCCCCCCCCCCCCC | 48.88 | 20873877 | |
421 | Phosphorylation | ESEGDIFTSPKRISG CCCCCCCCCCCCCCC | 44.44 | 26552605 | |
422 | Phosphorylation | SEGDIFTSPKRISGP CCCCCCCCCCCCCCC | 20.06 | 26552605 | |
427 | Phosphorylation | FTSPKRISGPECTTP CCCCCCCCCCCCCCC | 52.94 | 28450419 | |
432 | Phosphorylation | RISGPECTTPKASTS CCCCCCCCCCCCCCC | 44.46 | 29255136 | |
433 | Phosphorylation | ISGPECTTPKASTSA CCCCCCCCCCCCCCC | 34.16 | 29255136 | |
437 | Phosphorylation | ECTTPKASTSANNFT CCCCCCCCCCCCCCC | 29.08 | 23312004 | |
438 | Phosphorylation | CTTPKASTSANNFTK CCCCCCCCCCCCCCC | 36.40 | 23312004 | |
439 | Phosphorylation | TTPKASTSANNFTKS CCCCCCCCCCCCCCC | 26.89 | 28674419 | |
444 | Phosphorylation | STSANNFTKSGSTPL CCCCCCCCCCCCCCC | 26.82 | 23312004 | |
481 | Phosphorylation | VRKAKLGTPSNMPPN HHHHCCCCCCCCCCC | 33.70 | 26074081 | |
483 | Phosphorylation | KAKLGTPSNMPPNFP HHCCCCCCCCCCCCC | 45.67 | 26074081 | |
491 | Phosphorylation | NMPPNFPYISSPSVS CCCCCCCCCCCCCCC | 14.86 | 26074081 | |
493 | Phosphorylation | PPNFPYISSPSVSPP CCCCCCCCCCCCCCC | 30.28 | 26074081 | |
494 | Phosphorylation | PNFPYISSPSVSPPT CCCCCCCCCCCCCCC | 16.19 | 26074081 | |
496 | Phosphorylation | FPYISSPSVSPPTPE CCCCCCCCCCCCCCC | 36.86 | 26074081 | |
498 | Phosphorylation | YISSPSVSPPTPEPL CCCCCCCCCCCCCCH | 29.51 | 26074081 | |
501 | Phosphorylation | SPSVSPPTPEPLHKV CCCCCCCCCCCHHHH | 43.60 | 26074081 | |
517 | Phosphorylation | EEKTKLPSSVEVKKK HHHCCCCCHHHHHHH | 58.41 | 25159151 | |
518 | Phosphorylation | EKTKLPSSVEVKKKL HHCCCCCHHHHHHHH | 21.98 | 21815630 | |
522 | Acetylation | LPSSVEVKKKLKKEL CCCHHHHHHHHHHHH | 30.59 | 25953088 | |
568 | Phosphorylation | EKEKDKETGRETKYP HHHHHHHCCCCCCCC | 47.48 | - | |
572 | Phosphorylation | DKETGRETKYPWKEF HHHCCCCCCCCHHHH | 34.22 | - | |
581 | Sumoylation | YPWKEFLKEEEADPY CCHHHHHHHHCCCCC | 69.29 | 28112733 | |
601 | Acetylation | EFEDVDPKVKLKDGL ECCCCCCCCCCCCCH | 47.76 | 24848833 | |
621 | Acetylation | EKHKDKKKDREKGKK HHCCCHHHHHHHCCC | 68.69 | 88967 | |
625 | Acetylation | DKKKDREKGKKDKDK CHHHHHHHCCCCHHH | 76.54 | 88969 | |
628 | Acetylation | KDREKGKKDKDKREK HHHHHCCCCHHHHHH | 77.88 | 88965 | |
667 | Phosphorylation | ELALPLFSPATASRV HHCCCCCCCCHHHCC | 22.70 | 29255136 | |
670 | Phosphorylation | LPLFSPATASRVPAM CCCCCCCHHHCCCCH | 28.66 | 29255136 | |
672 | Phosphorylation | LFSPATASRVPAMLP CCCCCHHHCCCCHHH | 29.47 | 29255136 | |
677 | Sulfoxidation | TASRVPAMLPSLLPV HHHCCCCHHHHHHHH | 4.65 | 21406390 | |
746 | Sumoylation | KHKHEKIKVEPVALA HHHCCCCCCEECEEC | 52.17 | - | |
746 | Sumoylation | KHKHEKIKVEPVALA HHHCCCCCCEECEEC | 52.17 | 28112733 | |
755 | Phosphorylation | EPVALAPSPVIPRLT EECEECCCCCCCCEE | 26.62 | 30266825 | |
762 | Phosphorylation | SPVIPRLTLRVGAGQ CCCCCCEEEEECCCC | 17.50 | - | |
771 | Acetylation | RVGAGQDKIVISKVV EECCCCCEEEEEEEE | 30.87 | 25953088 | |
776 | Acetylation | QDKIVISKVVPAPEA CCEEEEEEEEECCCC | 35.81 | 19608861 | |
784 | Acetylation | VVPAPEAKPAPSQNR EEECCCCCCCCCCCC | 39.80 | 23236377 | |
794 | Phosphorylation | PSQNRPKTPPPAPAP CCCCCCCCCCCCCCC | 43.65 | 25159151 | |
809 | Phosphorylation | APGPMLVSPAPVPLP CCCCEEEECCCCCHH | 16.04 | 25159151 | |
830 | Phosphorylation | AGPALLPSPGPAASG HCCCCCCCCCCCCCC | 42.32 | 25627689 | |
846 | Phosphorylation | SAKAPVRSVVTETVS CCCCCHHHEEECEEE | 22.60 | 25627689 | |
849 | Phosphorylation | APVRSVVTETVSTYV CCHHHEEECEEEEEE | 24.63 | 25627689 | |
851 | Phosphorylation | VRSVVTETVSTYVIR HHHEEECEEEEEEEE | 15.47 | 25627689 |
Modified Location | Modified Residue | Modification | Type of Upstream Proteins | Gene Name of Upstream Proteins | UniProt AC of Upstream Proteins | Sources |
---|---|---|---|---|---|---|
Oops, there are no upstream regulatory protein records of TAF3_HUMAN !! |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of TAF3_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of TAF3_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
TBPL2_HUMAN | TBPL2 | physical | 17704303 | |
TBP_HUMAN | TBP | physical | 11438666 | |
KAT2A_HUMAN | KAT2A | physical | 11438666 | |
TAF10_HUMAN | TAF10 | physical | 11438666 | |
TAF12_HUMAN | TAF12 | physical | 11438666 | |
TAF13_HUMAN | TAF13 | physical | 11438666 | |
SP130_HUMAN | SAP130 | physical | 11438666 | |
TAF7_HUMAN | TAF7 | physical | 11438666 | |
TBP_HUMAN | TBP | physical | 21884934 | |
CTCF_HUMAN | CTCF | physical | 21884934 | |
TAF5_HUMAN | TAF5 | physical | 22939629 | |
TAF4_HUMAN | TAF4 | physical | 22939629 | |
TAF6_HUMAN | TAF6 | physical | 22939629 | |
IMA1_HUMAN | KPNA2 | physical | 15870280 | |
IMB1_HUMAN | KPNB1 | physical | 15870280 | |
H31T_HUMAN | HIST3H3 | physical | 17884155 | |
CDC23_HUMAN | CDC23 | physical | 26344197 | |
NP1L4_HUMAN | NAP1L4 | physical | 26344197 |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Acetylation | |
Reference | PubMed |
"Lysine acetylation targets protein complexes and co-regulates majorcellular functions."; Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.,Olsen J.V., Mann M.; Science 325:834-840(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-266 AND LYS-776, AND MASSSPECTROMETRY. | |
Phosphorylation | |
Reference | PubMed |
"Quantitative phosphoproteomic analysis of T cell receptor signalingreveals system-wide modulation of protein-protein interactions."; Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,Rodionov V., Han D.K.; Sci. Signal. 2:RA46-RA46(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-199; SER-229; SER-243;SER-297; SER-301 AND THR-501, AND MASS SPECTROMETRY. | |
"Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach."; Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.; Anal. Chem. 81:4493-4501(2009). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-229; SER-243; SER-291;SER-297 AND THR-364, AND MASS SPECTROMETRY. | |
"Automated phosphoproteome analysis for cultured cancer cells by two-dimensional nanoLC-MS using a calcined titania/C18 biphasic column."; Imami K., Sugiyama N., Kyono Y., Tomita M., Ishihama Y.; Anal. Sci. 24:161-166(2008). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-267, AND MASSSPECTROMETRY. | |
"Global, in vivo, and site-specific phosphorylation dynamics insignaling networks."; Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P.,Mann M.; Cell 127:635-648(2006). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-183; SER-410; SER-411;SER-413 AND SER-415, AND MASS SPECTROMETRY. | |
"Large-scale characterization of HeLa cell nuclear phosphoproteins."; Beausoleil S.A., Jedrychowski M., Schwartz D., Elias J.E., Villen J.,Li J., Cohn M.A., Cantley L.C., Gygi S.P.; Proc. Natl. Acad. Sci. U.S.A. 101:12130-12135(2004). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-229; SER-236; SER-243;SER-297 AND SER-410, AND MASS SPECTROMETRY. |